100 related articles for article (PubMed ID: 8733297)
1. Expression of cathepsin D during the progression of human gliomas.
Sivaparvathi M; Sawaya R; Chintala SK; Go Y; Gokaslan ZL; Rao JS
Neurosci Lett; 1996 Apr; 208(3):171-4. PubMed ID: 8733297
[TBL] [Abstract][Full Text] [Related]
2. Expression and immunohistochemical localization of cathepsin L during the progression of human gliomas.
Sivaparvathi M; Yamamoto M; Nicolson GL; Gokaslan ZL; Fuller GN; Liotta LA; Sawaya R; Rao JS
Clin Exp Metastasis; 1996 Jan; 14(1):27-34. PubMed ID: 8521613
[TBL] [Abstract][Full Text] [Related]
3. Expression and the role of cathepsin H in human glioma progression and invasion.
Sivaparvathi M; Sawaya R; Gokaslan ZL; Chintala SK; Rao JS
Cancer Lett; 1996 Jun; 104(1):121-6. PubMed ID: 8640738
[TBL] [Abstract][Full Text] [Related]
4. Overexpression and localization of cathepsin B during the progression of human gliomas.
Sivaparvathi M; Sawaya R; Wang SW; Rayford A; Yamamoto M; Liotta LA; Nicolson GL; Rao JS
Clin Exp Metastasis; 1995 Jan; 13(1):49-56. PubMed ID: 7820956
[TBL] [Abstract][Full Text] [Related]
5. Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas.
Rao CN; Lakka SS; Kin Y; Konduri SD; Fuller GN; Mohanam S; Rao JS
Clin Cancer Res; 2001 Mar; 7(3):570-6. PubMed ID: 11297250
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of cathepsin B in human glioblastoma cell lines.
Konduri S; Lakka SS; Tasiou A; Yanamandra N; Gondi CS; Dinh DH; Olivero WC; Gujrati M; Rao JS
Int J Oncol; 2001 Sep; 19(3):519-24. PubMed ID: 11494030
[TBL] [Abstract][Full Text] [Related]
7. Expression of cysteine protease inhibitors in human gliomas and meningiomas.
Sivaparvathi M; McCutcheon I; Sawaya R; Nicolson GL; Rao JS
Clin Exp Metastasis; 1996 Sep; 14(4):344-50. PubMed ID: 8878408
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin D is a potential serum marker for poor prognosis in glioma patients.
Fukuda ME; Iwadate Y; Machida T; Hiwasa T; Nimura Y; Nagai Y; Takiguchi M; Tanzawa H; Yamaura A; Seki N
Cancer Res; 2005 Jun; 65(12):5190-4. PubMed ID: 15958563
[TBL] [Abstract][Full Text] [Related]
9. Degradation of extracellular matrix protein tenascin-C by cathepsin B: an interaction involved in the progression of gliomas.
Mai J; Sameni M; Mikkelsen T; Sloane BF
Biol Chem; 2002 Sep; 383(9):1407-13. PubMed ID: 12437133
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin B and glioma invasion.
Demchik LL; Sameni M; Nelson K; Mikkelsen T; Sloane BF
Int J Dev Neurosci; 1999; 17(5-6):483-94. PubMed ID: 10571410
[TBL] [Abstract][Full Text] [Related]
11. Expression of cathepsin D and B in invasion and metastasis of squamous cell carcinoma.
Kawada A; Hara K; Kominami E; Hiruma M; Akiyama M; Ishibashi A; Abe H; Ichikawa E; Nakamura Y; Watanabe S; Yamamoto T; Umeda T; Nishioka K
Br J Dermatol; 1997 Sep; 137(3):361-6. PubMed ID: 9349330
[TBL] [Abstract][Full Text] [Related]
12. Lysosomal enzymes, cathepsins in brain tumour invasion.
Levicar N; Strojnik T; Kos J; Dewey RA; Pilkington GJ; Lah TT
J Neurooncol; 2002 May; 58(1):21-32. PubMed ID: 12160137
[TBL] [Abstract][Full Text] [Related]
13. Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D.
van der Stappen JW; Williams AC; Maciewicz RA; Paraskeva C
Int J Cancer; 1996 Aug; 67(4):547-54. PubMed ID: 8759615
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin B expression and localization in glioma progression and invasion.
Rempel SA; Rosenblum ML; Mikkelsen T; Yan PS; Ellis KD; Golembieski WA; Sameni M; Rozhin J; Ziegler G; Sloane BF
Cancer Res; 1994 Dec; 54(23):6027-31. PubMed ID: 7954439
[TBL] [Abstract][Full Text] [Related]
15. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
[TBL] [Abstract][Full Text] [Related]
16. [Cathepsin B expression and malignances and angiogenesis in gliomas].
Tang JJ; Jiang S; Mao BY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):212-4, 225. PubMed ID: 16608077
[TBL] [Abstract][Full Text] [Related]
17. Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis.
Mikkelsen T; Yan PS; Ho KL; Sameni M; Sloane BF; Rosenblum ML
J Neurosurg; 1995 Aug; 83(2):285-90. PubMed ID: 7542317
[TBL] [Abstract][Full Text] [Related]
18. Study of the biodistribution of fluorescein in glioma-infiltrated mouse brain and histopathological correlation of intraoperative findings in high-grade gliomas resected under fluorescein fluorescence guidance.
Diaz RJ; Dios RR; Hattab EM; Burrell K; Rakopoulos P; Sabha N; Hawkins C; Zadeh G; Rutka JT; Cohen-Gadol AA
J Neurosurg; 2015 Jun; 122(6):1360-9. PubMed ID: 25839919
[TBL] [Abstract][Full Text] [Related]
19. Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma.
Hau P; Ruemmele P; Kunz-Schughart LA; Doerfelt A; Hirschmann B; Lohmeier A; Koch H; Mueller A; Bogdahn U; Bosserhoff AK
Oncol Rep; 2004 Dec; 12(6):1355-64. PubMed ID: 15547763
[TBL] [Abstract][Full Text] [Related]
20. Detection of procathepsin D in rat milk.
Benes P; Koelsch G; Dvorak B; Fusek M; Vetvicka V
Comp Biochem Physiol B Biochem Mol Biol; 2002 Sep; 133(1):113-8. PubMed ID: 12223218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
